Q3 2016
Released Nov 10, 2016, after the close
10-Q filed Nov 10, 2016, 41 days after period end · 0001493152-16-014727
Q3 2016 · 10-Q
Revenue$475.00K$475.00K +48.4% vs Q3 2015−6.7% vs Q2 2016
Net Income-$706.00K-$706.00K N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted-$0.01-$0.01 N/M vs Q3 2015N/M vs Q2 2016
Gross Profit$316,000+90.4%
Operating Income-$637,000N/M
Operating Cash Flowderived-$790,000N/M
Free Cash Flowderived-$795,000—
Margins · derived
Gross margin66.5%+14.7 pt vs Q3 2015
Operating margin-134.1%+205.6 pt vs Q3 2015
Net margin-148.6%+32.9 pt vs Q3 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $475.00K | $320.00K | $491.00K | $418.00K |
| Net Income | -$706.00K | -$581.00K | $2.72M | -$2.41M |
| EPS Diluted | -$0.01 | -$0.02 | -$0.02 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR